(EMAILWIRE.COM, August 24, 2010 ) New York, NY -Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) plunged 22.19% to $7.96 on over 8.44 million shares. The company announced late Friday that the Joint Advisory Committee of the U.S. Food and Drug Administration, including the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee, voted 20-2 that the benefit/risk balance did not support the approval of JZP-6 for the treatment of fibromyalgia with the currently proposed Risk Evaluation Mitigation Strategy.


In the past one year of trading sessions, the stock advanced more than 25%.


To get FREE Stock newsletters, please sign up at http://www.otcblaze.com

Amgen, Inc. (NASDAQ:AMGN) slid 0.75% to $51.95 on over 3.47 million shares. Over the past 52-weeks, the stock traded within the range of $50.32-$62.51. Today, 3.47 million shares have been traded. In the past one year of trading sessions, the stock went down more than 14%.


At current market price, the market capitalization of the stock stood at $49.79 billion.


Dendreon Corporation (NASDAQ:DNDN) went down 2.67% to $37.20 after 2.28 million shares of trade. Today, the stock opened at $38.33 and was trading within the range of $37.14-$38.50. Over the past 52-weeks, the stock has been trading within the range of $22.57-$57.67.

Dendreon Corporation is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients.


Life Technologies Corp. (NASDAQ:LIFE) added 0.34% to $44.48. So far, the market capitalization of the stock stands at $8.15 billion. So far this year, the stock went down more than 15%.


Life Technologies Corporation formerly Invitrogen Corporation, incorporated 1989, is a biotechnology tools company. The Company delivers a range of products and services, including systems, instruments, reagents, software, and custom services.

About http://www.otcblaze.com

Our goal is to make money and help you make money too. We focus on stocks trading on the OTCBB and Pinksheets. We find that the opportunities in these markets to double or triple your investment in weeks, days or even hours is much greater than in other markets. We've seen it, we've done it, and now we want to help you get in on the action too. We do, on occasion, have some picks from the big boards too!!

Disclaimer

The disclaimer is to be read and fully understood before using our site or joining our email list.

PLEASE NOTE: The OTCBlaze.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Many times we are compensated to feature companies on our site which causes a conflict.

Contact Information:
Otcblaze.com
Editor
Tel: 732-229-0668
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.